Category Archives: Stem Cell Research

The Promise Of Stem Cell Research By: EFPIA … Continue reading →

Stem Cell Research and Policy George Daley and his team of stem cell rearchers from Harvard Medical School discuss the scientific and medical potential of stem cells, as well as the contr... By: Forum Network … Continue reading →

Written by Lidia Dinkova on April 30, 2014 After 15 years of University of Miami research on a unique adult bone marrow-derived stem cell and on a process that leaves the cell in a relatively pure form, the university and its tissue bank have partnered with a Marietta, GA, biomedical company to make the stem cell called the MIAMI cell commercially available in July. Vivex Biomedical Inc. invested in the research and development of the cell and licensed the technology from UM for orthopedic use, said company President and CEO Tracy S. Anderson. Vivex has contracted with the universitys tissue bank to develop the cell for commercial use. The company will pay an undisclosed royalty to UM from sales. Dr. H. Thomas Temple, professor of orthopedics, vice chair of orthopedic surgery and director of the University of Miami Tissue Bank, said South Florida is a viable market for the MIAMI cell. Just in bone [regeneration] alone theres an enormous market, and then if you take into consideration all the joint dysfunction that occurs with aging we have a significantly aged population, he said. If you think about the number of trauma cases we have down here where patients have open … Continue reading →

Miami (PRWEB) April 29, 2014 Global Stem Cells, Inc. and Global Stem Cell Foundation have announced plans to host the First International Symposium on Stem Cell Research in Buenos Aires, Argentina Oct. 2-4 2014. Some of the worlds leading stem cell researchers, treatment practitioners and investors, all committed to making the benefits of stem cell medicine available to everyone, will take advantage of the opportunity to discuss new ways to bridge the gap between bench science research science that is exclusively conducted in a lab settingand treatments delivered in the physicians office. These committed stem cell advocates from the U.S., Mexico, Greece, Hong Kong and other regions around the globe will be joined by a team of speakers, each one presenting the future of regenerative medicine in their specialty. Regenerative medicine as a field of is still in its infancy, according to Global Stem Cell Group CEO, Benito Novas. Our objective is to open a dialogue between the worlds medical and scientific communities in order to advance stem cell technologies and translate them into point-of-care medicine, Novas says. Our mission is to bring the benefits of stem cell therapies to the physicians office in full compliance with the highest standards … Continue reading →

Scientists have moved one step closer to creating and effective diabetes treatment by creating insulin-producing cells with the DNA of a diabetic woman. The approach could someday aid treatment of the Type 1 form of the illness, which is usually diagnosed in childhood and accounts for about 5 percent of diabetes cases in the U.S. The disease kills insulin-making cells in the pancreas. People with Type 1 diabetes use shots or a small pump to supply the hormone, which is needed to control blood sugar. The new work is a step toward providing genetically matched replacement cells for transplant, said Dieter Egli of the New York Stem Cell Foundation Research Institute in New York. He led the research, which was reported online Monday in the journal Nature. Doug Melton of the Harvard Stem Cell Institute, who was not involved with the work, called the paper an impressive technical achievement. But he said he believed the cells would be useful as a research tool rather than a source of transplants. They could help scientists uncover what triggers Type 1 diabetes, he said, which could in turn lead to better therapies. Scientists had previously made insulin cells that match diabetic patients by … Continue reading →

PUBLIC RELEASE DATE: 28-Apr-2014 Contact: David McKeon dmckeon@nyscf.org 212-365-7440 New York Stem Cell Foundation NEW YORK, NY (April 28, 2014) Using somatic cell nuclear transfer, a team of scientists led by Dr. Dieter Egli at the New York Stem Cell Foundation (NYSCF) Research Institute and Dr. Mark Sauer at Columbia University Medical Center has created the first disease-specific embryonic stem cell line with two sets of chromosomes. As reported today in Nature, the scientists derived embryonic stem cells by adding the nuclei of adult skin cells to unfertilized donor oocytes using a process called somatic cell nuclear transfer (SCNT). Embryonic stem cells were created from one adult donor with type 1 diabetes and a healthy control. In 2011, the team reported creating the first embryonic cell line from human skin using nuclear transfer when they made stem cells and insulin-producing beta cells from patients with type 1 diabetes. However, those stem cells were triploid, meaning they had three sets of chromosomes, and therefore could not be used for new therapies. The investigators overcame the final hurdle in making personalized stem cells that can be used to develop personalized cell therapies. They demonstrated the ability to make a patient-specific embryonic stem … Continue reading →

Since being the site of the first place to isolate stem cells in non-human primates, the University of Wisconsin has continued to pave the way for scientific research in the field. Stem cells are a type of undifferentiated cell most commonly found in embryos and fetuses that have the ability to develop into different, more specialized cells. Norman Fost, UW Stem Cell and Regenerative Medicine Center, said scientists speculate that stem cells could be used for understanding of normal and abnormal development, testing of drugs for efficacy and safety and tissue transplants. James Thompson, director of regenerative biology at UW, first proposed the creation of human embryonic stem cells in 1998 after being a part of the first group to isolate stem cells in 1995. At the time, Thompson was the chair of the UW Health Sciences Institutional Review Board, Fost said. Two UW committees developed the first guidelines for human embryonic stem cell research, which became the basis for the current U.S. guidelines created by an Institute of Medicine committee, Fost said. According to a 2010 Harris Interactive poll, 72 percent of American adults believe that embryonic stem cell research, which uses stem cells harvested from in vitro fetuses, … Continue reading →

Researchers hope stem cells could one day treat chronic conditions like diabetes and Parkinsons disease. Healthy bloom: Insulin, shown in red, is being produced by cells that started as embryonic stem cells derived from a patient with type 1 diabetes. A series of breakthroughs in cloning technology over the last year and a half are stoking hopes that cells could be used as treatments for patients with chronic, debilitating diseases such as diabetes and Parkinsons. In January 2013, researchers at the Oregon Health and Science University reported that they had successfully created embryonic stem cells from a human embryo formed when the nucleus of one persons cell was transferred into another persons egg that had its original nucleus removed (see Human Embryonic Stem Cells Cloned). That was the first time stem cells had been made from such a cloned embryo, and the advance provides a potential route by which scientists could create various kinds of replacement cells based on a patients own genome. Many other research teams are pursuing another method of creating stem cells from a patients own cells, but some believe cells made with the cloning technique could be more likely to develop into a wide variety of … Continue reading →

Scientists have used cloning technology to make stem cells from a woman with Type 1 diabetes that are genetically matched to her and to her disease. They hope to someday use such cells as tailor-made transplants to treat or potentially even cure the disease, which affects millions and which now has few treatment options other than careful diet and regular use of insulin. Its the second report his month of success in using cloning technology to make human embryonic stem cells the cells that eventually create a complete human being and that scientists hope to harness to treat diseases ranging from diabetes to Parkinsons and injuries that cause paralysis or organ damage. I think this is going to become reality, Dr. Dieter Egli of the New York Stem Cell Foundation, whose report is published in the journal Nature on Monday, told reporters. It may be a bit in the future but it is going to happen. The technique they use is called somatic cell nuclear transfer the same method used to make Dolly, the sheep who was the first mammal to be cloned, in 1996. Scientists remove the nucleus from a normal cell, clear the nucleus from a human egg … Continue reading →

Reverse Aging with Stem Cell Research By: Mohamad Salleh Sidek … Continue reading →